- Home
- HXHX vs FGEN Comparison
HXHX vs FGEN Comparison
Compare HXHX & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- FGEN
- Stock Information
- Founded
- HXHX 2003
- FGEN 1993
- Country
- HXHX China
- FGEN United States
- Employees
- HXHX N/A
- FGEN N/A
- Industry
- HXHX Trucking Freight/Courier Services
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- HXHX Industrials
- FGEN Health Care
- Exchange
- HXHX Nasdaq
- FGEN Nasdaq
- Market Cap
- HXHX 36.9M
- FGEN 33.5M
- IPO Year
- HXHX 2025
- FGEN 2014
- Fundamental
- Price
- HXHX $1.67
- FGEN $5.69
- Analyst Decision
- HXHX
- FGEN Strong Buy
- Analyst Count
- HXHX 0
- FGEN 1
- Target Price
- HXHX N/A
- FGEN $250.00
- AVG Volume (30 Days)
- HXHX 159.6K
- FGEN 49.2K
- Earning Date
- HXHX 01-01-0001
- FGEN 08-05-2025
- Dividend Yield
- HXHX N/A
- FGEN N/A
- EPS Growth
- HXHX N/A
- FGEN N/A
- EPS
- HXHX 0.26
- FGEN N/A
- Revenue
- HXHX $25,571,810.00
- FGEN $6,996,000.00
- Revenue This Year
- HXHX N/A
- FGEN N/A
- Revenue Next Year
- HXHX N/A
- FGEN N/A
- P/E Ratio
- HXHX $6.33
- FGEN N/A
- Revenue Growth
- HXHX N/A
- FGEN N/A
- 52 Week Low
- HXHX $1.29
- FGEN $4.50
- 52 Week High
- HXHX $6.29
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- FGEN 28.80
- Support Level
- HXHX N/A
- FGEN $5.16
- Resistance Level
- HXHX N/A
- FGEN $8.13
- Average True Range (ATR)
- HXHX 0.00
- FGEN 0.58
- MACD
- HXHX 0.00
- FGEN -0.26
- Stochastic Oscillator
- HXHX 0.00
- FGEN 11.13
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.